期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
TWENTY-FOUR HOUR DIURNAL CURVE COMPARISON OF COMMERCIALLY AVAILABLE BIMATOPROST 0.03% VERSUS TIMOLOL MALEATE 0.5%/OORZOLAMIDE 2% FIXED COMBINATION
1
作者 D.G.Day e.d.sharpe +3 位作者 C.J.Beischel J.N.Leech J.A.Stewart W.C.Stewart 《国际眼科杂志》 CAS 2003年第1期98-98,共1页
Purpose: To evaluate the efficacy and safety of bimatoprost 0.03 percent given every evening versus timolol maleate 0.5 per-cent/dorzolamide 2 percent fixed combination (TDFC) given twice daily in open-angle glaucoma ... Purpose: To evaluate the efficacy and safety of bimatoprost 0.03 percent given every evening versus timolol maleate 0.5 per-cent/dorzolamide 2 percent fixed combination (TDFC) given twice daily in open-angle glaucoma and ocular hypertensive patients. Design: A single-masked, two center, crossover comparison with two eight-week treatment periods following a four-week medicine free run-in period. Diurnal curve intraoc- 展开更多
关键词 青光眼 BIMATOPROST 疗效比较 马来酸噻吗络尔/多佐胺 昼夜IOP
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部